Heterotopic Ossification
📧 Sign up to get email alerts when something new happens for Heterotopic Ossification.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton. [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of andecaliximab in people with spinal cord injury at risk for heterotopic ossificati…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Heterotopic Ossification Prophylaxis [NA]
A completed clinical trial evaluating prophylaxis for heterotopic ossification following acetabular fracture has posted results.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: HO Prophylaxis Therapy for Distal Humerus Fractures [NA]
Trial update for a hyperprophylaxis therapy targeting heterotopic ossification in distal humerus fractures; the study is terminated with res…
-
CLINICAL_TRIALS withdrawal · 2015-03-10Clinical Trial Update: Study of Pamidronate for the Prevention of Heterotopic Ossification [NA]
The clinical trial studying pamidronate for prevention of heterotopic ossification has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Prevention of Heterotopic Ossification With Arcoxia After Total Hip Replacement [Phase 4]
Phase 4 trial evaluating etoricoxib (Arcoxia) to prevent heterotopic ossification after total hip replacement has completed, with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification [NA]
Clinical trial update examining celecoxib as primary prophylaxis to prevent combat-related heterotopic ossification.
-
CLINICAL_TRIALS withdrawal · 2012-03-21Clinical Trial Update: Naproxen for the Prevention of HO After Complex Elbow Trauma [Phase 4]
A Phase 4 trial of naproxen for preventing heterotopic ossification after complex elbow trauma has been withdrawn.